科技医药公司Disc Medicine(股票代码IRON)今日盘中大涨5.06%,引发市场广泛关注。公司突破性进展成为导火索,推动股价上涨。
分析人士指出,投资银行雷蒙德-詹姆斯和Leerink Partners对Disc Medicine的评级都予以上调,主要源于公司旗舰产品的临床进展。其中,雷蒙德-詹姆斯将Disc Medicine的投资评级从"跑赢大盘"上调至"强烈买入",目标价也从66美元大幅上调至110美元。
Leerink Partners则将Disc Medicine的目标价从65美元上调至85美元,对公司前景表示看好。分析师认为,Disc Medicine在研的新型干细胞疗法有望在治疗多种罕见和难治性疾病方面取得突破,市场潜力巨大。公司旗舰产品的积极临床进展,为未来商业化铺平了道路。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.